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Summary 
A mouse immunoglobulin G1 monoclonal antibody (mAb), MRC OX-62 (OX-62), was raised 
against density gradient-enriched rat veiled (dendritic) cells obtained from lymph. In suspensions 
of lymphoid cells, the OX-62 mAb only labeled cells with the characteristics of veiled cells. The 
OX-62 mAb was used with a magnetic cell sorter to enrich or deplete veiled cells, and the enriched 
veiled  cells  were  potent  stimulators  in  the  primary  allogeneic  mixed  leukocyte  reaction. 
Immunohistochemical staining of tissue sections showed that the OX-62 mAb did not label all 
classical dendritic cells and was not restricted to this cell type. In lymphoid tissues,  the labeling 
correlated with dendritic cells, but in skin, major histocompatibility complex class II + cells were 
OX-62-, while another CD3 + cell with dendritic morphology was strongly OX-62 + . It seems 
that the OX-62 mAb may be restricted to dendritic cells and probably to T/$ T cells. The OX-62 
mAb will be of use in delineating minor subsets of cells with dendritic morphdogy in various 
tissues. Sodium dodecyl sulfate-polyacrylamide  gel dectrophoresis analysis of veiled ceil-enriched 
populations  immunoprecipitated  with  the  OX-62  mAb  gave  bands  with  the  biochemical 
characteristics of an integrin. The OX-62 mAb recognized the c~-like subunit. 
D 
endritic cells are classified as a heterogeneous group of 
cells with dendritic morphology found in lymphoid 
and nonlymphoid tissues,  and as veiled cells in lymph (1). 
Dendritic cells originate from bone marrow but the lineage 
is unresolved (2). Attention focused on dendritic cells after 
the isolation of the spleen dendritic cell and the observation 
that these cells are the most potent accessory cells identified 
at inducing primary T  cell responses in vitro (3). The im- 
munoregnlatory role of dendritic ceils in vivo is implicated 
by their presence in the T-dependent areas of secondary lym- 
phoid organs (4, 5). Identification of dendritic ceils is based 
on properties of the isolated spleen dendritic cell, which in- 
dude dendritic morphology (6), constitutive expression of 
MHC class II (7), low phagocytic ability in vitro (8), and 
potent accessory function in the primary allogeneic MLR 
(3). The need for mAbs that are specific for dendritic calls 
is evident (9), but few useful mAbs are available (10-17), and 
anti-MHC class II mAbs are of limited value.  One major 
problem in generating dendritic cell mAbs is that it is difficult 
to obtain large numbers of dendritic cells for immunization 
and there are no call lines equivalent to normal dendritic cells 
(18-20). In this paper the production of a mouse IgG1 mAb 
(OX-62) useful for the purification of rat veiled ceils and recog- 
nizing an antigen with the biochemical properties of an inte- 
grin is described. 
Materials and Methods 
Animals.  BALB/c  (H-2  d) and DBA/2 (H-2  d) inbred mice were 
obtained from the Sir William Dunn School of Pathology (Ox- 
ford). F1 hybrids between these two strains were bred at the MRC 
Cellular  Immunology Unit  (Oxford).  PVG  (RT1 ~  and  AO 
(R.T1  u) specific pathogen-free inbred rats were obtained from the 
MRC Cellular Immunology Unit. Rats were used at 8-12 wk, 
except where stated otherwise. 
Mesenteric Lp~phadenectom?  Cecal,  mesenteric,  postgastric, and 
portal lymph nodes were surgically removed using blunt dissection 
from 90-g male PVG rats. Mesenteric  lymphadenectomized  rats were 
allowed to recover for a minimum of 6 wk before thoracic duct 
cannulation. 
Cell Populations.  Cell suspensions were prepared in PBS con- 
taining 0.25%  BSA. Thoracic duct leukocytes (TDL)  j were ob- 
tained by thoracic duct cannulation of normal and mesenteric lym- 
phadenectomized rats (21). Cells were collected  overnight in ice-cold 
glucose saline (22) containing  20 U/ml heparin.  Density gra- 
dient-enriched veiled cells were prepared from TDL obtained from 
mesenteric lymphadenectomized rats (MLNX TDL) by centrifu- 
gation over Nycoprep  TM 1.068 (Nycomed, Oslo, Norway). Thy- 
mocytes, splenocytes, and lymph node cells were obtained by 
removing appropriate organs and teasing into single call suspen- 
1 Abbreviations used in this  paper: MLNX TDL, thoracic  duct leukocytes 
obtained from mesenteric  lymphadenectomized  rats; RAM, rabbit anti- 
mouse; TDL. thoracic duct leukocytes. 
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and separated  over Isopaque-Ficoll.  Bone marrow cells were ob- 
tained by flushing the marrow cavity of the femur with PBS. Resi- 
dent peritoneal exudate cells were obtained from the peritoneal cavity 
of freshly killed rats. Elicited peritoneal exudate cells were obtained 
from the peritoneal cavity 4 d after intraperitoneal injection of 10 
ml of thioglycollate broth. Con A blasts were obtained after a 3-d 
culture of lymph node cells at 106/ml in RPMI 1640 supplemented 
with 5% heat-inactivated FCS, 2 mM glutamine, 1 mM sodium 
pyrnvate, 2.5  x  10 -s  M  2-ME,  and antibiotics (supplemented 
RPMI), and 5/~g/ml Con A. Con A blasts  were separated  over 
Isopaque-Picoll and washed in oe-methyl-D-mannoside (20 mg/ml). 
LPS blasts  were obtained after a 2-d culture of lymph node cells 
at 106/ml in supplemented RPMI and 10/~g/ml LPS. 
rnAbs and Antibody Conjugates.  The OX-62 hybridoma was pro- 
duced by immunizing a BALB/c mouse with rat PVG density gra- 
dient-enriched veiled cells obtained from the cannulated thoracic 
duct of mesenteric lymphadenectomized rats. The immunization 
procedure was a combination of three intravenous and intraperitoneal 
injections with 5-10  x  106 cells at monthly intervals.  5 d after 
the last injection, the splenocytes were fused with NSO myeloma 
cells according to the method of Galfr~ and Milstein (23).  After 
growth of the hybrid cell lines,  supernatants were screened  for 
specificity by immunohistochemistry (see below). Selected hybrid- 
omas were cloned twice by limiting dilution. Ascites fluid was pre- 
pared in (BALB/c  x  DBA/2)Ft mice pretreated with pristane. 
The  subdass  of  the  OX-62  mAb  was  determined  using  an 
anti-mouse monoclonal isotyping kit (Serotec, Kidlington, Oxon, 
England). 
Other mAbs used were SN3 (mouse anti-squid Sgp 1) (24), OX-6 
(mouse anti-rat MHC class II, IgG1) (25), OX-8 (mouse anti-rat 
CDS, IgG1) (26), OX-12 (mouse anti-rat IgG ~ chain, IgG2a) (27), 
OX-17 (mouse anti-rat MHC class II, IgG1) (28), OX-21 (mouse 
anti-human C3b inactivator, IgG1) (29), and OX-42 (mouse anti-rat 
CD18/CD11b, IgG2a) (30). mAbs were used as tissue culture su- 
pernatants, purified IgG from ascites fluid (31), and purified IgG 
from ascites fluid conjugated with biotin (32). 
Other antibodies used were rabbit anti-mouse IgG mAb con- 
jugated with peroxidase (RAM-peroxidase) (Dako, High Wycombe, 
Bucks,  England), affinity-purified  rabbit F(ab')2 anti-mouse IgG 
mAb (Serotec) conjugated with fluorescein (KAM-FITC) (32), bi- 
otin (RAM-biotin)  (32),  and iodine (mI-KAM) (33), and fluo- 
rescein-conjugated  goat anti-mouse IgG1 (GAM-FITC) (Southern 
Biotechnology Associates,  Inc., Birmingham,  AL). 
Flow Cytofluorography. Labeling  of cells  for  analysis  on  a 
FACScan  |  (Becton Dickinson & Co., Mountain View, CA) was 
performed as described  previously (32).  Cells were gated on the 
scatter profiles to exclude dead cells and erythrocytes. 
Magnetic Cell Sorting.  The principle of the magnetic cell sorting 
system and conditions for labeling and sorting cells have been de- 
scribed in detail (34, 35). All incubations, washes, and sorting were 
carried out at 4~  in PBS containing 5 mM EDTA and 10 mM 
NAN3. Briefly, 109 cells were labeled in 5-ml mAb tissue culture 
supernatant for 30 rain, washed, labeled in 1 ml RAM-biotin (10 
/~g/rul) for 30 rain, washed, labeled in 1 ml avidin-FITC (25/~g/ml) 
(Becton Dickinson & Co., Cowley, Oxford, England) for 30 min, 
washed, and finally incubated in 1 ml containing 10 #1 biotinylated 
superparamagnetic microbeads (Becton Dickinson & Co.) for 5 rain. 
Labeled cells were added to the appropriately sized column in the 
magnetic fidd. Unlabeled cells were collected in the first 10-15-ml 
volume. The column was  washed to remove unlabeled, weakly 
bound, and dead cells. Magnetically labeled cells were duted from 
the column outside the magnetic field. In some experiments en- 
riched and depleted Populations were further depleted of con- 
taminating cells by a second magnetic sort. The etficiency of deple- 
tion and enrichment was determined by flow cytofluorography using 
a FACScan  | 
MLR.  5  x  10  s responder cells were cocukured with different 
numbers of irradiated (20 Gy) stimulator cells in supplemented 
RPMI in 96-well round-bottomed microtiter plates for 72 h at 37~ 
in  a  5%  COs  incubator.  Samples  were  pulsed  with  0.5  /~Ci 
[3H]TdK and incubated for a further 18 h. Samples were then har- 
vested for incorporation of [3H]TdR. In some experiments OX-62 
mAb and appropriate control mAbs were added as purified IgG 
at the start of culture. 
Preparation of Specimens  for Imraunohistochemistty.  For cryostat 
sections, organs were removed from rats, embedded in OCT (Miles, 
Elkhart,  IN),  and  frozen  in  2-methylbutane  cooled in  liquid 
nitrogen. 5-/ira cryostat sections were cut onto four-spot glass slides 
(C. A. Hendley, Essex, England), air dried, and stored desiccated 
at  -70~  For epidermal ear sheets, rat ears were split longitudi- 
nally and  incubated  in  116  mM  NaCI,  2.6  mM  KC1, 8  mM 
Na2HPO4,  1.4 mM KH2PO4, and 20 mM EDTA, pH 7.3, for 2 h 
at 37~  on a rotator (36). Epidermal sheets were separated using 
watchmaker's forceps under a dissecting microscope.  For isolated 
cells, cytospin preparations were made using a cytocentrifuge, air 
dried, and stored desiccated  at  -70"C. 
Immunohistocheraistry.  The peroxidase  method was  used for 
staining sections as described previously (37). All incubations were 
carried out at 4"C. Briefly, cryostat sections, epidermal sheets, and 
cytospin preparations were fixed in ethanol for 10 min, washed, 
incubated with mAb tissue culture supernatant for 60 min, except 
for epidermal ear sheets, which were incubated overnight, washed, 
incubated with  RAM-peroxidase  (25  /zg/ml)  for 60  min,  and 
washed. Peroxidase was visualized using 3,3'-diaminobenzidine  tetra- 
hydrochloride. Staining was enhanced using 0.01 M imidazole in 
the 3,Y-diaminobenzidine tetrahydrochloride solution. Slides were 
lightly counterstained with Harris' haematoxylin, dehydrated, and 
mounted in DePeX (BDH Ltd., Pooh, England). Immunofluores- 
cence was used for double labeling of epidermal ear sheets. Fixed 
tissues were incubated with the first mAb tissue culture supema- 
tant overnight, washed, and incubated with GAM-FITC (15/zg/ml) 
for 90 min. After washing, tissues were incubated with 30% mouse 
serum for 60 min, incubated with the second biotinylated IgG mAb 
(10/~g/ml) for 4 h, washed, incubated with Texas red-conjugated 
streptavidin (10/~g/ml) (Southern Biotechnology Associates, Inc.) 
for 90 rain, washed, and mounted in Citifluor glycerol solution 
(Citifluor Ltd., London, England). 
Cell Surface Radioiodination  and Imraunoprecipitaa'on.  107 density 
gradient-enriched veiled  cells were surface  labeled  by an H202 
lactoperoxidase-catalyzed radioiodination  method (38). Labeled cells 
were solubilized in 500 ~1 lysis buffer comprising 10 mM Tris-HCL, 
pH 7.5-8, 150 mM NaC1, 5 mM EDTA, 1% NP-40, 1 mM PMSF, 
and 5 mM iodoacetamide for 30 rain at 4~  Samples (2.5  x  106 
cell equivalents)  were centrifuged and the supernatants precleared 
for 30 rain at 4oC on a rotating wheel with 100/zl of a 10% sus- 
pension of Sepharose CL-4B beads (Pharmacia,  Uppsala, Sweden), 
which had been covalently coupled to purified mAb IgG using cy- 
anogen bromide ("~ 10 mg purified mAb IgG/ml CL,4B beads) 
(39). Predearing was repeated three times. Precleared samples were 
directly immunoprecipitated for 1 h at 4~  on a rotating wheel 
with 30/~1 of a 10% solution of Sepharose CL4B beads covalently 
coupled to purified mAb IgG. Immunopredpitated samples were 
washed in the following buffers: (a) 10 mM Tris-HCl, pH 8.0, con- 
taining 500 mM NaC1, 0.5% NP-40, and 0.05% SDS; (b) 10 mM 
Tris-HCl, pH 8.0, containing 150 mM NaCI, 0.5% NP-40, 0.5% 
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8.0, containing 0.05% SDS. Samples  and molecular weight markers 
(Rainbow  TM  protein  molecular  weight  markers;  Amersham, 
Bucks, England) were boiled in 15 #1 sample buffer for 5 min and 
run on 7.5%  SDS-PAGE using  a mini-gel apparatus (Bio-Kad 
Laboratories, Richmond, CA) (40). Gels were fixed, dried, and ex- 
posed to Hyperfilm  TM  (Amersham) at  -70~ 
Western Blotting.  Veiled  cell-enriched lysates prepared as de- 
scribed for immunoprecipitation  were run on 7.5%  SDS-PAGE 
using a mini-gel apparatus (Bio-Rad  Laboratories).  Protein was trans- 
ferred to nitrocdlulose  (HybondZM-C-extra;  Amersham) using a 
mini trans-blot dectrophoretic transfer apparatus (Bio-gad Labora- 
tories). Membranes were placed in PBS containing 5% dried nonfat 
milk powder for 24 h at 4~  Ascites fluid containing the appro- 
priate mAb was added to give a final concentration of 1-50 #g/ml, 
and the membranes were incubated for 2 h at 4~  with rocking. 
The membranes were washed three times in PBS/0.05%  Tween 
20 before addition of nSI-KAM (sp act '~1.5 #Ci/#g IgG at a di- 
lution of 1@ cpm/ml) in PBS/0.05% Tween 20/1% BSA. After 
incubation for 1 h at 4~  the membranes were washed three times 
in PBS/0.05% Tween 20 and exposed to Hyperfilm  TM at  -70~ 
Results and Discussion 
Production of the 0X-62 mA~  Out of a total of four fu- 
sions and screening ,,o2,000 wells, one hybridoma secreting 
a mouse anti-rat IgG1 mAb (OX-62) was sdected on the 
basis of immunohistochemical staining of cells with dendritic 
cell morphology in tissue sections of lymphoid organs.  In 
the current studies, <10% of the mAbs produced were against 
MHC class II antigens, although anti-MHC class II mAbs 
have been reported to comprise up to 50%  of positive hy- 
bridomas in anti-dendritic call fusions (16).  A  number of 
interesting  mAbs  against  endothelial  determinants  were 
produced. 
Expression of the  0X-62  Antigen  by Different Leukocyte 
T~es.  Fig. 1 shows FACScan |  profiles of different isolated 
leukocyte types labeled with the OX-62 mAb. Positive profiles 
were only obtained with density gradient-enriched veiled cells 
from MLNX TDL (Fig. 1 C). Immunohistochemical staining 
of cytospin preparations of MLNX TDL and TDL confirmed 
that veiled ceils were the only cell type labded (Fig. 3, I and 
J). Thymocytes (Fig. 1 F), splenocytes (Fig. 1 G), and lymph 
node calls (Fig.  1/4),  tissues  known to have OX-62 + cells 
in low numbers by immunohistochemical staining of sections 
(Fig.  3, A, C, and E), gave staining with the OX-62 mAb 
at  a level barely distinguishable from background on the 
FACScan |  indicating that the OX-62 + ceils are normaUy 
present at too low a frequency to be dearly detectable by this 
method. Resident peritoneal exudate ceils (Fig. 1/), thioglycol- 
late didted peritoneal exudate cells (Fig. 1.]), LPS blasts (Fig. 
1 K),  and Con  A  blasts  (Fig.  1 L),  were OX-62-.  The 
OX-62 mAb failed to labd PBL and bone marrow cells when 
analyzed on a FACScan |  (Fig.  1, D and E) and by immuno- 
histochemical  staining  of cytospin preparations  (data  not 
shown). 
Enrichment of Dendritic Cells.  The infrequent distribution 
of dendritic cells makes isolation difficult. Dendritic cells can 
either be obtained in suspension in lymph or from lymphoid 
organs with or without enzyme digestion and adherence. Den- 
dritic cells represent ,,,1% or less of these populations; there- 
fore, further enrichment is dependent either on positive or 
negative sdection using relevant mAbs and/or nonspecific 
separation using density gradients (41,  42). 
The ability of the OX-62 mAb to enrich and deplete OX- 
62-labeled cells was assessed after magnetic sorting pheno- 
typically by flow cytofluorography using a FACScan |  mor- 
phologically, and functionally using magnetically sorted ceils 
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Figure  1.  Binding  of  OX-62 
mAb  to different leukocyte  types 
isolated from PVG rats. Cells were 
labeled  with  saturating  levels  of 
OX-62  mAb  (-)  and  isotype- 
matched  negative  control  OX-21 
mAb (- -) followed by a second in- 
cubation with KAM-FITC. Bound 
mAb was measured by flow cyto- 
fluorography. A, TDL; B, MLNX 
TDL; C, MLNX TDL gradient en- 
riched for veiled cells (~50%  en- 
richment);  D,  PBL;  E,  bone 
marrow  cells;  F,  thymocytes;  G, 
splenocytes; H,  lymph node cells; 
I, resident peritoneal exudate cells; 
J, thioglycollate elicited peritoneal 
exuclate cells; K, LPS blasts; L, Con 
A  blasts.  Note all profiles are su- 
perimposed except for C  and D. 





CELL  NUMBER 
Figure 2.  Comparison of OX-62 + cell-enriched and -depleted popu- 
lations as stimulators in an MLR. 5  x  10  s AO TDL responders depleted 
of OX-6-, OX-17-, OX-8-, and OX-12-1abeled  cells by magnetic sorting 
were stimulated with different numbers of unseparated PVG MLNX TDL 
(O), FVG MLNX TDL enriched for OX-62 + cells by magnetic sorting 
(B),  and PVG MLNX TDL depleted of OX-62 + cells by magnetic 
sorting (El).  Data are the mean and SD of quadruplicate cultures. 
as  stimulators  in  the primary allogeneic MLR.  Magnetic 
sorting gave >75% enrichment of OX-62 mAb-labeled cells. 
The potency of the cell populations separated after labeling 
with the OX-62 mAb and used as stimulators in the primary 
allogeneic MLR is shown in Fig. 2.  The OX-62-enriched 
ceils were potent stimulators, with 1.22  x  103 cells per cul- 
ture, providing the same stimulus as 15.5  x  103 unseparated 
cells. The depleted cells had 12% of the activity of the un- 
separated cells,  indicating that the OX-62 + cells were the 
major stimulating cell in the MLR.  It can be argued that 
almost  all  the stimulating activity is  from OX-62 + cells, 
since the activity of the depleted cells is in accord with the 
level of OX-62 + cell contamination.  Magnetic sorting of 
OX-62 mAb-labded cells represents a useful method for en- 
riching for veiled cells. To obtain purer populations of veiled 
calls (>90%) in high yields, magnetically sorted cells can be 
sorted by flow cytofluorography using a FACS  |  (data not 
shown). 
Effect of the 0X-62 mAb on the Primary Allogeneic MLR. 
OX-62 IgG added at the start of culture in a concentration 
range from 1.25 ng/ml to 2.5 #g/m1 had no effect on the 
MLR between CD4 responders from AO rats (i.e.,  OX-6, 
OX-17,  OX-8,  and OX-12 mAb-labeled and magnetically 
depleted TDL) and unseparated MLNX TDL stimulators from 
PVG rats (data not shown), indicating that the OX-62 an- 
tigen is not essential for T  cell activation. 
Distribution o.f  the 0X-62 Antigen in Lymphoid Organs.  The 
distribution of the OX-62 antigen in lymphoid organs (Fig. 
3) mostly coincided with previous reports of dendritic cell 
distribution based on microscopic and immunohistochem- 
ical studies (4, 6,  11,  13-16, 43-47).  All cells labeled with 
the OX-62 mAb had a dendritic cell morphology. In the 
thymus, 0X-62 + cells were present in the medulla forming 
a diffuse network, which was concentrated at the cortico- 
medullary junction  (Fig.  3  A).  OX-62 +  cells  were  also 
present in the lobular septa with occasional ceils present in 
the cortex (Fig.  3 A), correlating with the large scattered 
ceils observed in the cortex in bone marrow chimeras (43). 
In the spleen,  OX-62 + cells  were concentrated in  the T- 
dependent areas, particularly around the region of the cen- 
tral arteriole but also throughout the red pulp (Pig.  3 C). 
The OX-62 + cells in the red pulp were rounded and more 
strongly stained compared with cells in the T-dependent areas 
where the borders were difficult to  define. OX-62 + cells 
were present in the marginal zones and the peripheral white 
pulp infrequently (Fig.  3  C).  In the cervical lymph node, 
OX-62 +  cells  were present  in  the  subcapsular  sinus,  T- 
dependent areas of the cortex, and in the medulla, but were 
rare in the follicles (Fig. 3 E). In the Peyer's patch, OX-62 + 
cells were present in the interfollicular areas and in the epi- 
thdial dome regions, but were rare in the follicles  (Fig.  3 
C). Background staining with an isotype-matched mAb OX- 
21 was negligible (Fig.  3, B, D, F, and H). No difference 
in OX-62 staining was found between FVG, AO, DA, and 
Lewis rat  strains,  and OX-62 + cells were present in con- 
genitally athymic PVG nude rats (PVG rnu/rnu) (data not 
shown), confirming previous results using anti-MHC class 
II mAbs (48). 
Distribution of the 0X-62 Antigen in Nonlymphoid Organs. 
OX-62 +  cells  with  dendritic morphology that  coincided 
with known MHC class II dendritic cell distribution (48, 
49) were present in the lamina propria of the small intestine 
(Fig. 4, A  and B), interstitium of the lung, portal triads of 
the liver, glomeruli of the kidney, islets of Langerhans of the 
pancreas,  and epithelium of the choroid plexus (data not 
shown). Lack of OX-62 + cells in heart and skeletal musde 
(data not shown) contrasts with previous studies using anti- 
MHC dass II mAbs (48-50). 
Unexpectedly, the OX-62 mAb revealed populations of OX- 
62 + MHC class II- ceils in the epithelium of the small in- 
testine and in the epidermis of the skin.  In the epithelium 
of the small intestine, only granular MHC class II staining 
has been reported (Fig.  4 B; and 47), but this staining was 
not associated with the OX-62 + intraepithelial cells (Fig. 4 
A). In epidermal sheets, OX-62 mAb labeling primarily re- 
vealed cells with a marked dendritic morphology comprising 
the cell body and nonoverlapping dendritic processes (Fig. 
4  C) in contrast to OX-6 mAb labeling,  which primarily 
revealed cells with less prominent dendrites (Pig. 4 D). Double 
immunofluorescence showed that most if not all the OX- 
62 + and MHC class II + populations were nonoverlapping 
(Fig. 4, E, F, and G). The OX-62 + MHC class II- cells in 
the  small  intestine  and  the  skin  were  CD3 +  (data  not 
shown) and probably represent 3//~ T cells (51-53). Overall, 
the results indicate that the OX-62 mAb may label some but 
not all dendritic cells and probably "y/~ T cells. Furthermore, 
the identification of nonoverlapping OX-62 + MHC  class 
II-  and OX-62-  MHC  class II + populations  in the skin 
with a similar distribution raises the question as to which 
cells migrate into the afferent lymphatics giving rise to the 
OX-62 + MHC class II + veiled ceils. Previous work has in- 
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lymphoid tissues.  Cryostat  sections (5 ~tm) and 
cytospin  preparations hbeled using the indirect im- 
munoperoxidase method. A, thymus hbeled with 
OX-62 mAb. Cells in the medulla (M) note con- 
centration  at the cortico-medullaryjunction, scat- 
tered cells in the corte~ (C) and infrequent  cells 
in the lobular  septae (1~-) labeled. B, thymus la- 
beled with isotype-matched negative control OX- 
21 mAb. C, spleen hbded with OX-62 mAb. Cells 
in the T cdl areas (~ of  the white pulp surrounding 
the central  arteriole  (1~), infacquent  cells in the 
B cell areas (B) of the white pulp,  and cells in the 
red pulp (RP)  hbeled. D,  spleen hbehd with 
OX-21 mAb. E, cervical  lymph node labeled with 
OX-62 mAb. Cells in the subcapsular sinus (1~) 
and paracortex (P) labeled, but few cells in the fol- 
licle (F) labeled. F, cervical lymph node labeled 
with OX-21 mAb. G, Peyer's  patch labeled with 
OX-62 mAb. Cells in  the  interfollicular T-de- 
pendent areas (T) and dome epithelium (It,') la- 
beled, but few cells in the follicle (F) hbded. H, 
Peyer's patch labeled with OX-21 raAb I, PVG 
MLNX TDL labeled with  OX-62 mAb. Note 
labeling of veiled cells with dendritic morphology 
(l~).J, PVG TDL labehd with OX-62 mAb.  A-H 
x60,  I and J,  x375. 
dicated  that  MHC  class  II + Langerhans  cells  (54)  are  the 
probable  precursors  (55-58). 
Distribution of tke 0X-62 Antigen in Autoimmune Disease 
Models.  The presence of cells  with dendritic morphology 
in autoimmune diseases has been documented (59-61); there- 
fore,  the distribution of OX-62 + cells  in cryostat  sections 
of organs from rat modds with autoimmune diabetes  (62) 
and experimental  allergic encephalomyelitis  (63) was exam- 
ined. Increased OX-62 mAb labding of cells in the islets of 
Langerhans with leukocyte infiltrates in the pancreas of rats 
with autoimmune diabetes was found when compared with 
control nondiabetic rats (data not shown). Similarly, increased 
OX-62  mAb labeling of cells  in lesions in the spinal cord 
of rats with experimental allergic encephalomyelitis was found, 
in contrast  to  normal rats where OX-62 +  cells  were rare 
(data not shown). It has not been established  whether the 
increased labeling represents upregulation of the OX-62 an- 
tigen or migration of OX-62 + cells  into  the lesions. 
Molecular Characterization of the  0X-62  Antigen.  The 
OX-62  mAb  immanoprecipitated  four  noncovahntly  as- 
sociated bands from radioiodinated density gradient-enriched 
veiled cells under both nonreducing (Fig. 5, A, lane I) and 
reducing (lane 2) conditions: a major band of ~150 kD, a 
minor band of ~120  kD  that migrated  faster under non- 
reducing conditions, and two lower bands of <30 kD. The 
OX-62 mAb precleared all bands immunoprecipitated by the 
OX-62 mAb but some contaminants remained in the lowest 
apparent molecular mass band, which coincided with the dye 
1461  Brenan  and  Puklavec Figure 4.  Labeling  of OX-62 + MHC class II- cells in the intraepithelial  region of the small intestine and in epidermal  ear sheets. PVG rat small 
intestine cryostat  sections (5 ~m) (A and/3) and epidermal ear sheets (C-G). A-D labeled using the indirect immunoperoxidase  method; and E-F 
labeled using double immunofluorescence.  A, OX-62 mAb. Cells in the lamina propria with dendritic  morphology  and smaller intraepithelial  cells 
labeled (--*). B, OX-6 mAb. Cells in the lamina  propria and cells with cytoplasmic  processes extending  into the epithdium  labeled  (lib). Note granular 
OX-6 mAb labeling of the epithelium (/3, --*) compared with the OX-62 mAb intraepithelial  cell labeling (A, --*). C, OX-62 mAb. Note labeling 
of dendritic processes. D, OX-6 mAb. Note rounded  morphology  and less prominent dendrites. Nonspecific  staining  represent hair follicles  (C and 
D, b-). E, GAM-HTC  detection  of OX-62 mAb. F, streptavidin  Texas red detection  of OX-6 IgG biotin-conjugated  mAb. G, combined  GAM-FITC 
detection of the OX-62 mAb and streptavidin  Texas red detection  of OX-6 IgG biotin-conjugated  mAb. Note nonoverlapping  populations  of OX-62 + 
and OX-6  + cells. Examples  of nonoverlapping  OX-62  + cells (-*) in E and G are missing  in F. Examples  of OX-6  + cells (A) in F and G are missing 
in E. Large fluorescent areas represent autofluorescence  of hair follicles  (E-G). A-D,  x250; E and F,  ￿ 
front (Fig. 5 A, lane 3). The 150-kD band was the only band 
detected by the OX-62 mAb on Western blots (Fig. 5 B, lane 
1). The biochemical properties of the OX-62 antigen are char- 
acteristic of an integrin. Integrins consist of noncovalently 
associated cx (120-210-kD)  and/3 (95-220-kD) subunits (64). 
The strong  150-kD  band present under nonredudng and 
reducing conditions is r  subunit like and the weaker 120-kD 
band, which migrated faster under nonreducing conditions 
due to internal disulphide bonding (64),  is/5 subunit like. 
The stronger 150-kD band would be predicted as the OX-62 
mAb recognizes the 150-kD band, and the noncovalent as- 
sociation of or//5 integrin subunits, which is weak under im- 
munoprecipitation conditions, results in some coprecipita- 
tion of cx with/3 (65)  and/3 with r  (66).  The/5 subunit 
is not/31,  based on preclearing experiments with a cross- 
reactive antipeptide antibody (65) foUowed by immunopre- 
cipitation (data not shown), and not/32, based on preclear- 
ing experiments with the OX-42 mAb (CD18/CDllb) fol- 
lowed by immunopredpitation (data not shown).  /31,/32, 
and/37 (/5p) are present in lymphoid cells (64).  The c~ sub- 
unit is not cx  3, cr s, or c~  6, based on preclearing experiments 
with cross-reactive  antipeptide antibodies (66) foUowed by 
immunoprecipitation (data not shown). The o~ subunits are 
grouped into those that have I domains and those that un- 
dergo posttranslational cleavage (~, r  s, and c~  6) to give a 
cytoplasmic/transmembrane/extracellular  fragment (25 kD) 
1462  Monodonal  Antibody  Raised against Rat Veiled Cells Figure  5.  (A)  lmmunoprecipitation of the  OX-62 antigen. A  12sI 
surface-hbeled  PVG veiled  ceil-erLriched  lysate  was run on 7.5% SDS-PAGE 
before autoradiography.  Samples  were unreduced  (Lane  I) or reduced  (lanes 
2-4). (Lanes I and 2) OX-62 mAb immunoprecipitation  after control SN3 
mAb preclear. (Lane  3) OX-62 mAb immunoprecipitation  after OX-62 
mAb preclear. (Lane  4) Control  SN3 mAb immunoprecipitation  after  control 
SN3 mAb preclear. (B) Western blotting of the OX-62 antigen. A PVG 
veiled cell-enriched lysate was run under reducing conditions on 7.5% 
SDS-PAGE and electroblotted  to nitrocellulose.  The nitrocellulose  mem- 
branes were probed with (lane I) OX-62 mAb, (lane 2) isotype-matched 
negative control OX-21 mAb, and 12SI-RAM  as the second mAb before 
autoradiography.  Numbers indicate  the apparent molecular  mass (kD) de- 
termined from marker proteins. 
and a larger extracellular fragment (130-150  kD) (64).  The 
two <30-kD bands (Fig. 5 A, lanes I  and 2) may represent 
alternative splicing of the cytoplasmic tail similar to that de- 
scribed  for c~  3 and  ot  6 (67).  The  presence  of cleaved frag- 
ments under nonreducing (Fig.  5 A,  lane I)  and reducing 
(lane 2)  conditions is not identical to previously described 
cleaved cz subunits, which are disulphide bonded (64), with 
the exception of o~M29~  (68,  69).  The M290 mAb,  which 
identifies/37 as deduced from sequence homology (70,  71) 
associated with a novel ot subunit,  shows similar biochem- 
ical characteristics  to the OX-62  antigen.  It has been pro- 
posed that M290 (68-71),  HML-1 (72,  73), bet-ACT8 (74), 
and RGL-1 (75), which labds rat veiled cells (data not shown), 
recognize an homologous antigen present on intraepithelial 
lymphocytes. 
Concluding Statement.  OX-62 mAb seems to be restricted 
to dendritic cells in lymphoid and nonlymphoid organs, and 
to CD3 + cells with dendritic morphology, which are prob- 
ably 3'//J T  cells.  The OX-62  antigen has the biochemical 
properties  of an integrin.  The mAb will be useful for cell 
purification, delineating lineage relationships among cells with 
dendritic morphology,  and for molecular studies. 
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